Astragalus Membranaceus Treatment Protects Raw264.7 Cells from Influenza Virus by Regulating G1 Phase and the TLR3-Mediated Signaling Pathway

Table 1

IC0, IC10, and IC25 of AMI in each time period.

Drug action time	IC0 (mg/ml)	IC10 (mg/ml)	IC25 (mg/ml)
24 h	301	412	578
48 h	190	338	472
72 h	9.5	40	92